Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Beginning Cash Balance: 2009-2024

Historic Beginning Cash Balance for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $1.2 billion.

  • UNITED THERAPEUTICS's Beginning Cash Balance rose 17.51% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 40.28%. This contributed to the annual value of $1.2 billion for FY2024, which is 25.65% up from last year.
  • As of FY2024, UNITED THERAPEUTICS's Beginning Cash Balance stood at $1.2 billion, which was up 25.65% from $961.2 million recorded in FY2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Beginning Cash Balance peaked at $1.2 billion during FY2024, and registered a low of $738.4 million during FY2020.
  • Moreover, its 3-year median value for Beginning Cash Balance was $961.2 million (2023), whereas its average is $1.0 billion.
  • Data for UNITED THERAPEUTICS's Beginning Cash Balance shows a peak YoY rose of 25.65% (in 2024) over the last 5 years.
  • Over the past 5 years, UNITED THERAPEUTICS's Beginning Cash Balance (Yearly) stood at $738.4 million in 2020, then rose by 0.04% to $738.7 million in 2021, then rose by 21.13% to $894.8 million in 2022, then rose by 7.42% to $961.2 million in 2023, then climbed by 25.65% to $1.2 billion in 2024.